Skip to main content

Table 2 Univariate COX regression analyses of clinicopathologic factors associated with OS

From: Integrated analysis of methylation-driven genes and pretreatment prognostic factors in patients with hepatocellular carcinoma

Parameters univariate analysis
HR(95% CI)
P value
T stage 2.845 (1.768–4.580) < 0.001
New tumor events 5.222 (2.584–10.555) < 0.001
Cancer status 2.460 (1.519–3.982) < 0.001
BMI 0.680 (0.424–1.090) 0.109
Risk score 1.814 (1.123–2.930) 0.015
HCC risk factors 0.737 (0.437–1.243) 0.252
Surgical method 0.409 (0.251–0.667) < 0.001
Residual tumor 1.415 (0.513–3.899) 0.502
Race 1.175 (0.726–1.903) 0.512
Grade 1.130 (0.670–1.825) 0.617
Gender 0.887 (0.538–1.462) 0.639
Other tumor 1.150 (0.496–2.668) 0.744
Age 0.933 (0.567–1.536) 0.785